NCT01140659

Brief Summary

Compare the results obtained with video-assisted sympathectomy performed in two distinct levels ganglionic (third versus fourth thoracic ganglion) for the treatment of palmar hyperhidrosis, through a blind randomized clinical trial using an objective method to measure the sweat before and after the operation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2007

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2007

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2009

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2010

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

June 7, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 9, 2010

Completed
Last Updated

June 22, 2010

Status Verified

May 1, 2010

Enrollment Period

2.2 years

First QC Date

June 7, 2010

Last Update Submit

June 21, 2010

Conditions

Keywords

HyperhidrosisThoracic sympathectomyObjective measurement of sweat

Outcome Measures

Primary Outcomes (1)

  • Objective measurement of sweat before and after surgery (video-assisted thoracic sympathectomy) T3 and T4.

    We used an objective method for measuring sweat, checking the "TEWL (transepidermal water loss) measured by the"VapoMeter". This is a portable instrument that functions noninvasively. It has a closed measurement chamber that eliminates external interference from air currents and enables precise metering of transepidermal water loss (TEWL). The evaporation rate is calculated from the rise in relative air humidity inside the closed chamber of the device, and this value is quantified in g/m²/h (increase in the water mass per unit time per unit of evaporation area).

    12 months

Secondary Outcomes (3)

  • Assessment of quality of life.

    12 months

  • Incidence of the compensatory hyperhidrosis

    12 months

  • Intensity of the compensatory hyperhidrosis

    12 months

Study Arms (1)

Objective measurement of sweat

OTHER

We selected 40 patients from February 2007 to May 2009. All participants were randomized into two groups of 20 patients (G3 and G4) and underwent the sympathectomy, being followed for 12 months. We used an objective method for measuring sweat, checking the "TEWL (transepidermal water loss) measured by the "VapoMeter", and evaluated the quality of life before and after the operation. Also studied were: incidence and intensity of the compensatory hyperhidrosis.

Procedure: Video-assisted sympathectomy

Interventions

All participants were randomized into two groups of 20 patients (G3 and G4) and underwent video-assisted sympathectomy, being followed for 12 months. During this period, the subjects completed a questionnaire about quality of life and carried out the measurements of sweat by VapoMeter.

Also known as: Thoracic sympathectomy, Endoscopic thoracic sympathectomy
Objective measurement of sweat

Eligibility Criteria

Age15 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Being determined to accomplish the procedure, because such a statement depends on the level of discomfort suffered by the patient.
  • Absence of previous thoracic surgery.
  • Concordance with the completion of informed consent.
  • Preoperative normal, including chest radiograph, electrocardiogram, blood count, sodium, potassium, urea, creatinine, glucose and thyroid hormones.

You may not qualify if:

  • Patients with BMI\> 25.
  • Pregnancy.
  • Younger than 15 and more than 45 years.
  • Heart disease that may contraindicate the procedure (congestive heart failure, coronary insufficiency, cardiac arrhythmias, symptomatic, acute myocardial infarction, etc.).
  • Acute infections or chronic.
  • Bleeding disorder.
  • Neoplasms.
  • Inflammatory diseases of pulmonary or pleural.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine - University of São Paulo.

São Paulo, São Paulo, 05403-010, Brazil

Location

MeSH Terms

Conditions

Hyperhidrosis

Condition Hierarchy (Ancestors)

Sweat Gland DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • José Ribas M de Campos

    Professor of Thoracic Surgery - University of São Paulo - Medical College

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 7, 2010

First Posted

June 9, 2010

Study Start

February 1, 2007

Primary Completion

May 1, 2009

Study Completion

February 1, 2010

Last Updated

June 22, 2010

Record last verified: 2010-05

Locations